精準給藥市場－全球產業規模、佔有率、趨勢、機會及預測，依病患類型、工具、軟體、藥物類別、地區及競爭格局分類，2020-2030年預測

2024年全球精準給藥市場規模為1.8834億美元，預計到2030年將以7.72%的複合年成長率成長至2.9433億美元。精準給藥是指在各種工業和醫療應用中，對物質（通常是微量物質）進行精確可控的輸送。推動市場擴張的關鍵因素包括：電子製造業對製程最佳化和小型化的需求不斷成長；製藥和生物技術行業對品質控制的嚴格要求；以及各行業對自動化技術的日益普及。

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球精準給藥市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依患者類型（兒科、老年科、多重用藥患者、終末器官功能障礙患者、其他）
  • 依工具分類（基於生理的藥物動力學 (PBPK) 模型、非線性混合效應 (NLME) 模型）
  • 依軟體類型（基於Web、基於桌面）
  • 依藥物類別（抗生素、抗黴菌藥、免疫抑制劑、抗癲癇藥、抗腫瘤藥、抗憂鬱藥、其他）
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美精準給藥市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲精準給藥市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區精準給藥市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲精準給藥市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲精準給藥市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購（如有）
• 產品發布（如有）
• 最新進展

第13章：全球精準給藥市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• InsightRX Inc.
• Tabula Rasa HealthCare, Inc.
• Healthware, Inc. (PrecisePK)
• Vesynta Limited
• Oxular Limited
• Accent Therapeutics, Inc.
• Rapport Therapeutics, Inc.
• HNP Mikrosysteme GmbH
• Fluid-O-Tech Srl
• Psycheceutical, Inc.

第16章：策略建議

第17章調查會社について,免責事項

The Global Precision Dosing Market, valued at USD 188.34 Million in 2024, is projected to experience a CAGR of 7.72% to reach USD 294.33 Million by 2030. Precision dosing involves the accurate and controlled delivery of substances, often in minute quantities, across diverse industrial and medical applications. Key drivers supporting market expansion include the increasing demand for process optimization and miniaturization in electronics manufacturing, stringent quality control requirements in the pharmaceutical and biotech sectors, and the growing adoption of automation technologies across various industries.

Key Market Drivers

The Global Precision Dosing Market is significantly propelled by advancements in pharmacogenomics and genetic profiling. These scientific developments enable a more profound understanding of individual patient responses to medications by analyzing genetic variations that influence drug metabolism, efficacy, and safety. Such insights are fundamental to tailoring therapeutic regimens with unprecedented accuracy, moving away from generalized treatment protocols. For instance, in an article published in *The Pharmacogenomics Journal*, October 2024, a pharmacogenomics-enriched comprehensive medication management program was associated with 39% fewer inpatient and 39% fewer emergency department visits, highlighting the clinical utility and direct benefits of genetically guided dosing. This precision minimizes adverse drug reactions and optimizes therapeutic outcomes, fostering greater confidence in individualized treatments.

Key Market Challenges

High initial capital expenditure presents a significant impediment to the expansion of the Global Precision Dosing Market. The substantial upfront investment required for advanced precision dosing systems directly limits their adoption, particularly among smaller enterprises or those operating with constrained capital budgets. This financial barrier delays the integration of such technologies, even when their long-term benefits in terms of efficiency and quality are evident.

Key Market Trends

The strategic integration of artificial intelligence and machine learning into dosing protocols is a pivotal trend transforming the Global Precision Dosing Market. These advanced technologies enhance the accuracy and efficiency of drug administration by analyzing vast datasets to predict optimal dosages, identify patient-specific responses, and refine treatment regimens. According to the US Food and Drug Administration's (FDA) Division of Pharmaceutical Manufacturing Assessment III, in a June 2024 address, approximately 40% of companies are already utilizing AI in various capacities within pharmaceutical manufacturing, indicating a significant move towards intelligent systems for production and delivery. This adoption extends to precision dosing, where AI-driven models can continuously learn and adapt, leading to improved therapeutic outcomes.

Key Market Players

• InsightRX Inc.
• Tabula Rasa HealthCare, Inc.
• Healthware, Inc. (PrecisePK)
• Vesynta Limited
• Oxular Limited
• Accent Therapeutics, Inc.
• Rapport Therapeutics, Inc.
• HNP Mikrosysteme GmbH
• Fluid-O-Tech Srl
• Psycheceutical, Inc.

Report Scope:

In this report, the Global Precision Dosing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Precision Dosing Market, By Patient Type:

• Paediatrics
• Geriatrics
• Patients on Polypharmacy
• Patients with End Organ Dysfunction
• Others

Precision Dosing Market, By Tools:

• Physiologically Based Pharmacokinetic (PBPK) Modeling
• Non-Linear Mixed Effects (NLME) Modeling

Precision Dosing Market, By Software:

• Web-Based
• Desktop-Based

Precision Dosing Market, By Drug Class:

• Antibiotics
• Antimycotics
• Immunosuppressives
• Antiepileptics
• Antitumoral Drugs
• Antidepressants
• Others

Precision Dosing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Precision Dosing Market.

Available Customizations:

Global Precision Dosing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Precision Dosing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Patient Type (Paediatrics, Geriatrics, Patients on Polypharmacy, Patients with End Organ Dysfunction, Others)
  • 5.2.2. By Tools (Physiologically Based Pharmacokinetic (PBPK) Modeling, Non-Linear Mixed Effects (NLME) Modeling)
  • 5.2.3. By Software (Web-Based, Desktop-Based)
  • 5.2.4. By Drug Class (Antibiotics, Antimycotics, Immunosuppressives, Antiepileptics, Antitumoral Drugs, Antidepressants, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Precision Dosing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Patient Type
  • 6.2.2. By Tools
  • 6.2.3. By Software
  • 6.2.4. By Drug Class
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Precision Dosing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Patient Type
      • 6.3.1.2.2. By Tools
      • 6.3.1.2.3. By Software
      • 6.3.1.2.4. By Drug Class
  • 6.3.2. Canada Precision Dosing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Patient Type
      • 6.3.2.2.2. By Tools
      • 6.3.2.2.3. By Software
      • 6.3.2.2.4. By Drug Class
  • 6.3.3. Mexico Precision Dosing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Patient Type
      • 6.3.3.2.2. By Tools
      • 6.3.3.2.3. By Software
      • 6.3.3.2.4. By Drug Class

7. Europe Precision Dosing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Patient Type
  • 7.2.2. By Tools
  • 7.2.3. By Software
  • 7.2.4. By Drug Class
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Precision Dosing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Patient Type
      • 7.3.1.2.2. By Tools
      • 7.3.1.2.3. By Software
      • 7.3.1.2.4. By Drug Class
  • 7.3.2. France Precision Dosing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Patient Type
      • 7.3.2.2.2. By Tools
      • 7.3.2.2.3. By Software
      • 7.3.2.2.4. By Drug Class
  • 7.3.3. United Kingdom Precision Dosing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Patient Type
      • 7.3.3.2.2. By Tools
      • 7.3.3.2.3. By Software
      • 7.3.3.2.4. By Drug Class
  • 7.3.4. Italy Precision Dosing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Patient Type
      • 7.3.4.2.2. By Tools
      • 7.3.4.2.3. By Software
      • 7.3.4.2.4. By Drug Class
  • 7.3.5. Spain Precision Dosing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Patient Type
      • 7.3.5.2.2. By Tools
      • 7.3.5.2.3. By Software
      • 7.3.5.2.4. By Drug Class

8. Asia Pacific Precision Dosing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Patient Type
  • 8.2.2. By Tools
  • 8.2.3. By Software
  • 8.2.4. By Drug Class
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Precision Dosing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Patient Type
      • 8.3.1.2.2. By Tools
      • 8.3.1.2.3. By Software
      • 8.3.1.2.4. By Drug Class
  • 8.3.2. India Precision Dosing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Patient Type
      • 8.3.2.2.2. By Tools
      • 8.3.2.2.3. By Software
      • 8.3.2.2.4. By Drug Class
  • 8.3.3. Japan Precision Dosing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Patient Type
      • 8.3.3.2.2. By Tools
      • 8.3.3.2.3. By Software
      • 8.3.3.2.4. By Drug Class
  • 8.3.4. South Korea Precision Dosing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Patient Type
      • 8.3.4.2.2. By Tools
      • 8.3.4.2.3. By Software
      • 8.3.4.2.4. By Drug Class
  • 8.3.5. Australia Precision Dosing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Patient Type
      • 8.3.5.2.2. By Tools
      • 8.3.5.2.3. By Software
      • 8.3.5.2.4. By Drug Class

9. Middle East & Africa Precision Dosing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Patient Type
  • 9.2.2. By Tools
  • 9.2.3. By Software
  • 9.2.4. By Drug Class
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Precision Dosing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Patient Type
      • 9.3.1.2.2. By Tools
      • 9.3.1.2.3. By Software
      • 9.3.1.2.4. By Drug Class
  • 9.3.2. UAE Precision Dosing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Patient Type
      • 9.3.2.2.2. By Tools
      • 9.3.2.2.3. By Software
      • 9.3.2.2.4. By Drug Class
  • 9.3.3. South Africa Precision Dosing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Patient Type
      • 9.3.3.2.2. By Tools
      • 9.3.3.2.3. By Software
      • 9.3.3.2.4. By Drug Class

10. South America Precision Dosing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Patient Type
  • 10.2.2. By Tools
  • 10.2.3. By Software
  • 10.2.4. By Drug Class
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Precision Dosing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Patient Type
      • 10.3.1.2.2. By Tools
      • 10.3.1.2.3. By Software
      • 10.3.1.2.4. By Drug Class
  • 10.3.2. Colombia Precision Dosing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Patient Type
      • 10.3.2.2.2. By Tools
      • 10.3.2.2.3. By Software
      • 10.3.2.2.4. By Drug Class
  • 10.3.3. Argentina Precision Dosing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Patient Type
      • 10.3.3.2.2. By Tools
      • 10.3.3.2.3. By Software
      • 10.3.3.2.4. By Drug Class

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Precision Dosing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. InsightRX Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Tabula Rasa HealthCare, Inc.
• 15.3. Healthware, Inc. (PrecisePK)
• 15.4. Vesynta Limited
• 15.5. Oxular Limited
• 15.6. Accent Therapeutics, Inc.
• 15.7. Rapport Therapeutics, Inc.
• 15.8. HNP Mikrosysteme GmbH
• 15.9. Fluid-O-Tech Srl
• 15.10. Psycheceutical, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer